Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months. Read More
The pilot project is designed to determine if wastewater testing can provide early signals about the spread of the virus. Read More
MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers. Read More
An individual's microbiome consists of a diverse set of bacterial strains that encode rich information on its colonization and evolutionary history. Here, we introduce a versatile and straightforward reference-based strain tracking approach (StrainTrack) that determines whether distinct metagenomes carry closely-related strains based on gene presence and absence profiles. Read More
Satellite imaging documents the environmentally devastating loss of Southeast Asia’s peatlands. Read More
A faster way to develop immune-stimulating drugs has yielded a potential treatment for yellow fever and holds promise for covid-19. Read More
An international team of researchers, led by MIT Professor Ram Sasisekharan, has now developed a potential treatment for yellow fever. Their drug, an engineered monoclonal antibody that targets the virus, has shown success in early-stage clinical trials in Singapore. Read More
An international team of researchers, led by MIT Professor Ram Sasisekharan, has now developed a potential treatment for yellow fever. Their drug, an engineered monoclonal antibody that targets the virus, has shown success in early-stage clinical trials in Singapore. Read More
An Indian American-led research team at the Massachusetts Institute of Technology, using specialized nanoparticles, has developed a way to monitor pneumonia or other lung diseases by analyzing the breath exhaled by the patient.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases. Read More
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells. Read More
Tychan, a Singapore-based clinical-stage biotechnology company, is initiating Phase 1 clinical trials to evaluate TY027, the first novel monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19.
Study reveals drainage, deforestation of the region’s peatlands, which leads to fires, greenhouse emissions, land subsidence. Read More
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Researchers screening wastewater in Massachusetts for the novel coronavirus found more traces of the pathogen than expected given the number of confirmed cases in the area.
As the novel coronavirus continues to spread and devastate communities, the United States is still struggling to do enough testing to understand the true scale of the epidemic. Now, researchers around the country are looking for new tools to help track how the virus is spreading. Testing your sewage may be one way.
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
A group of researchers are launching clinical trials for a drug they hope can treat respiratory failure in COVID-19 patients more effectively.
Read More
MIT biochemists can trap and visualize an enzyme as it becomes active — an important development that may aid in future drug development.
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
Read More
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
A new approach reveals how different tissues contribute to inflammatory diseases such as ulcerative colitis.
Monitoring the plant hormone ethylene could reveal when fruits and vegetables are about to spoil.
Scientists discover the structure of an enzyme, found in the human gut, that breaks down a component of collagen.
In the United States, there are thousands of industrial sites contaminated by the irresponsible disposal of chemical waste. The higher than expected frequency of cancer cases near these sites has caused alarm, since many of the chemical contaminants found at these sites have been linked to the development of long-term health problems, including cancer. As leaders of the Massachusetts Institute of Technology Superfund Research Program, Dr Jennifer Kay (Research Scientist and Research Translation Director) and Professor Bevin Page Engelward (Program Director) are using their expertise to investigate the genetic factors that influence susceptibility to adverse health outcomes following exposure to environmental chemicals.
Heads John and Ellen Essigmann, as well as Associate Head Steven Hall, to depart from Simmons.
Study tracks pollution from state to state in the 48 contiguous United States.
Research underscores infection is not a common hospital transmission.
The protective substance is an important barrier between a woman’s body and the environment. Here’s how researchers are using it to understand health.
Study suggests noninvasive spectroscopy could be used to monitor blood glucose levels. Read more
Developed by MIT chemists; A new test using specific liver cells can quickly detect cancer-causing DNA damage. Read more